Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novel Drug Shows Benefits in Rare C3G and Primary IC-MPGN
SAN DIEGO — The investigational drug pegcetacoplan, a C3/C3b inhibitor, showed significant benefits in the treatment of patients with C3 glomerulopathy or primary immune complex–mediated membranoproliferative glomerulonephritis (IC-MPGN) in the largest trial of its kind of these rare and debilitating…
English